Enterprise Value

51.74M

Cash

35.0M

Avg Qtr Burn

-7.543M

Short % of Float

0.39%

Insider Ownership

40.13%

Institutional Own.

19.29%

Qtr Updated

12/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
CNM-Au8 Details
Multiple sclerosis

Phase 3

Initiation

CNM-Au8 Details
Amyotrophic lateral sclerosis

Phase 3

Initiation

CNM-Au8 Details
Amyotrophic lateral sclerosis

Phase 2

Data readout

CNM-Au8 Details
Multiple sclerosis

Phase 2

Update

CNM-Au8 Details
Parkinson's disease

Failed

Discontinued

Failed

Discontinued